Sanofi-Aventis U.s. LLC
Morristown, NJ Doing business as Sanofi - Aventis U S LLC Part of Sanofi US Services Inc.
- UEI
- VLDVVLDQMML4
- CAGE
- 6TXG7
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Morristown, NJ
YPG9PFGL54W5
-
Parent
Morristown, NJ
YPG9PFGL54W5
- SAM.gov registration date
- Physical address
- 100 Morris St, Morristown, NJ 07960, USA
- Website
- sanofi.com
- Founded
- 1973
- Employees
- 50K-100K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Task order 2 under RFP-12-100-SOL-00016 | Office of the Assistant Secretary for Preparedness and Response | $0 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Astellas Pharma US, Inc. | Northbrook, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Astor Drugs | Holtsville, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Civica RX | Lehi, UT | 325412 Pharmaceutical Preparation Manufacturing |
| Endo Usa, Inc. | Malvern, PA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Sanofi-Aventis U.S. LLC is a foreign-owned, for-profit pharmaceutical company registered in the System for Award Management (SAM) since December 2012, with its primary location in Bridgewater, New Jersey. The company specializes in developing and supplying pharmaceutical products to various federal agencies, with a focus on medical treatments including insulin products, diabetes-related medications, and other critical healthcare solutions. As a key pharmaceutical vendor, Sanofi-Aventis U.S. LLC provides essential medical products to multiple federal healthcare systems, demonstrating its significant role in supporting government healthcare procurement needs.
The company holds three primary federal contract indefinite delivery vehicles (IDVs) with substantial ceiling values across different contract types. A notable $465,370,525.50 single-award Indefinite Delivery Contract with the Department of Veterans Affairs National Acquisition Center focuses on human insulin products, covering pens, vials, and insulin analogs for agencies including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Another $5,000,000 Blanket Purchase Agreement is specifically for TZIELD, a pharmaceutical product, while a $4,958,982,930 Federal Supply Schedule contract through the Veterans Integrated Service Network 12 covers drugs, pharmaceuticals, and hematology-related products. These contracts are primarily administered under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule, with contract periods extending through 2026-2028 and no specific set-asides, indicating the company's competitive positioning in federal pharmaceutical procurement.
Quick answers
Is Sanofi-Aventis U.s. LLC registered in SAM.gov?
Yes. Sanofi-Aventis U.s. LLC's SAM.gov registration is active through June 26, 2027.
Which contract vehicles does Sanofi-Aventis U.s. LLC hold?
Sanofi-Aventis U.s. LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Sanofi-Aventis U.s. LLC's most recent federal award?
Sanofi-Aventis U.s. LLC's most recent federal contract award is Task order 2 under RFP-12-100-SOL-00016 (HHSO10033001T), from Office of the Assistant Secretary for Preparedness and Response, on September 25, 2013.
On GovTribe
See Sanofi-Aventis U.s. LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors